Monitor key technologies and future developments through our unique approach to quantifying medical progress over time.
Horizon Scanning
Monitor key technologies and future developments through our unique approach to quantifying medical progress over time.
Case Studies
A leading life insurer, required up-to-date insights on emerging trends and recent advancements in the biomedical field that could impact their portfolio. We became a strategic partner in longevity risk management, delivering a semi-annual horizon scanning report as part of our service. We delivered timely and comprehensive analysis of key longevity factors, including advancements in biomedical research and medical technologies.
Stochastic multi-disciplinary Infectious Disease Modelling, supporting insurers’ pandemic risk assessment.
Transform disease-specific insurance with our multi-disciplinary morbidity modelling expertise, delivering advanced pricing and risk assessment tools.
Unlock mortality insights with our multi-disciplinary modelling approach, combining health science and actuarial expertise for precise risk assessment
We leverage sophisticated imputation techniques to estimate portfolio biometrics and other critical risk factor data.
Leverage Crystallise’s expert panel of modellers and health science specialists to parameterise cutting-edge mortality and morbidity risk models.
Accelerate life insurance research decisions with Evidence Mapping, a budget-friendly, time-efficient literature review.
Crystallise empower management decisions with comprehensive insights through biomedical evidence synthesis.
Crystallise offers a flexible, evidence-based, and clinically informed modelling approach for even the most complex diseases and health outcomes.
Our synthetic sample generation approach ensures accurate representation of real-world populations for modelling clinical outcomes/intervention effectiveness.